BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di Martino L, Tosello V, Peroni E, Piovan E. Insights on Metabolic Reprogramming and Its Therapeutic Potential in Acute Leukemia. Int J Mol Sci 2021;22:8738. [PMID: 34445444 DOI: 10.3390/ijms22168738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sharma ND, Keewan E, Matlawska-Wasowska K. Metabolic Reprogramming and Cell Adhesion in Acute Leukemia Adaptation to the CNS Niche. Front Cell Dev Biol 2021;9:767510. [PMID: 34957100 DOI: 10.3389/fcell.2021.767510] [Reference Citation Analysis]
2 Zhu J, Zhang Y, Chen X, Bian Y, Li J, Wang K. The Emerging Roles of LINC00665 in Human Cancers. Front Cell Dev Biol 2022;10:839177. [DOI: 10.3389/fcell.2022.839177] [Reference Citation Analysis]
3 Nakamura A, Suzuki S, Kanasugi J, Ejiri M, Hanamura I, Ueda R, Seto M, Takami A. Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma. Int J Mol Sci 2021;22:10761. [PMID: 34639102 DOI: 10.3390/ijms221910761] [Reference Citation Analysis]
4 Jiang N, Zhang X, Chen Q, Kantawong F, Wan S, Liu J, Li H, Zhou J, Lu B, Wu J. Identification of a Mitochondria-Related Gene Signature to Predict the Prognosis in AML. Front Oncol 2022;12:823831. [DOI: 10.3389/fonc.2022.823831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhao H, Jiang Y, Lin F, Zhong M, Tan J, Zhou Y, Liu L, Li G, Deng M, Xu B. Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells. Exp Hematol Oncol 2022;11:29. [PMID: 35581670 DOI: 10.1186/s40164-022-00282-1] [Reference Citation Analysis]